The study published in the American Journal of Cancer Research shows that the Food and Drug Administration-approved medication crizotinib (also known by its name brand, Xalkori) is effective at inhibiting the growth of non-small cell lung cancer with the most common genetic mutations.
Existing Drug Shows Promise in Treating Most Prevalent Type of Lung Cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Nearly three decades after first discovering the tumor suppressing Par-4 “super gene” that has been shown to kill cancer cells, a team of researchers at the University of Kentucky Markey Cancer Center is now learning about its role in preventing obesity – a disease that affects more than 1.9 billion people worldwide.